BiomX Stock Forum

$BiomX (PHGE.US)$ Reuters· 1 min ago
Biomx Inc - FDA Grants Bx004 Fast Track and Orphan Drug Designation

$BiomX (PHGE.US)$
BiomX Inc. (NYSE American: PHGE) has announced a 1-for-10 reverse stock splitof its common stock, effective August 26, 2024. The stock will continue trading under the symbol 'PHGE' with a new CUSIP number. This decision follows stockholder approval on July 9, 2024, and final ratio determination by the Board on August 8, 2024. The split will reduce outstanding shares from approximately 178,958,447 to 17,895,...

$BiomX (PHGE.US)$ BiomX Announced A One-for-ten Reverse Split, Effective August 26

$BiomX (PHGE.US)$ no volume

$BiomX (PHGE.US)$
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
The findings will be presented in an oral presentation and an ePoster at the 47th European Cystic Fibrosis Conference, which is taking place June 5-8, 2024, in Glasgow, United Kingdom, and in a Rapid Fire oral presentation and a poster at the American Society for Microbiology (ASM) Microbe 2024 meeting, being held June 13-1...

$BiomX (PHGE.US)$ BiomX Announces Closing Of The Acquisition Of Adaptive Phage Therapeutics And Concurrent $50 Million Financing

$BiomX (PHGE.US)$
​$Wisa Tech ​​get in why it's cheap

$BiomX (PHGE.US)$ anybody in here hold till tomorrow?

BiomX Merges with Adaptive Phage Therapeutics, Secures $50 Million Financing.
In a significant development in the biotech sector, BiomX Inc. (NYSEAMERICAN: PHGE), a clinical-stage microbiome company, has announced its entry into a merger agreement with Adaptive Phage Therapeutics (APT). The merger is complemented by a concurrent financing deal amounting to $50 million, marking a major milestone for both entities involved. $BiomX (PHGE.US)$
...